Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 862,853 | 812,987 | 705,709 | 604,718 | 789,509 |
| Cost of Goods | 43,874 | 39,869 | 38,028 | 29,220 | 36,323 |
| Gross Profit | 818,979 | 773,118 | 667,681 | 575,498 | 753,186 |
| Operating Expenses | 709,119 | 538,577 | 526,873 | 476,921 | 589,280 |
| Operating Income | 110,734 | 235,410 | 140,836 | 98,797 | 164,229 |
| Interest Expense | 752 | 439 | 358 | 359 | 428 |
| Other Income | 10,038 | -25,502 | 31,155 | -29,116 | 4,301 |
| Pre-tax Income | 120,020 | 209,469 | 171,633 | 69,322 | 168,102 |
| Income Tax | -443,831 | 27,730 | 22,177 | 15,787 | 18,252 |
| Net Income Continuous | 563,851 | 181,739 | 149,456 | 53,535 | 149,850 |
| Net Income | $563,851 | $181,739 | $149,456 | $53,535 | $149,850 |
| EPS Basic Total Ops | 2.56 | 0.82 | 0.68 | 0.24 | 0.71 |
| EPS Basic Continuous Ops | 2.56 | 0.82 | 0.68 | 0.24 | 0.70 |
| EPS Diluted Total Ops | 2.54 | 0.82 | 0.67 | 0.24 | 0.72 |
| EPS Diluted Continuous Ops | 2.54 | 0.82 | 0.67 | 0.24 | 0.72 |
| EBITDA(a) | $125,592 | $250,101 | $155,293 | $112,635 | $177,395 |